7月2日，远大医药（股票代码：00512）发布截至2026年6月30日的股份变动月报表。公告显示，公司本月无新增发行、回购或注销股份，股本整体维持不变。
根据公告，远大医药集团有限公司的法定/注册股本构成为100,000,000,000股普通股，每股面值为港币0.01元，法定/注册股本合计约为港币1,000,000,000元，与上月相比无变动。已发行股本及库存股方面，与上月一致，已发行普通股股份数目为3,549,571,148股，库存股份数目为0股，合计3,549,571,148股。
公告同时显示，远大医药符合香港联交所对于公众持股量的最低要求。公司本月无股份认购权证、可换股票据及其他股权激励计划事项的变动，也未发生新的回购或注销。公司表示已符合适用的上市规则和相关法律法规规定。公告由公司秘书傅天忠签署。
截至6月末，远大医药股本总数保持稳定，未有新增发行及回购活动。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.